AVEO Oncology
AVEO
#7367
Rank
C$0.73 B
Marketcap
C$21.29
Share price
0.00%
Change (1 day)
180.85%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -C$37.21 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are C$94.31 Million. In 2021 the company made an earning of -C$75.7 Million a decrease over its 2020 earnings that were of -C$50.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$37.21 Million-50.85%
2021 -C$75.7 Million49.9%
2020 -C$50.5 Million-479.04%
2019 C$13.32 M-276.17%
2018 -C$7.57 Million-91.79%
2017 -C$92.14 Million142.38%
2016 -C$38.02 Million78.51%
2015 -C$21.3 Million-71.55%
2014 -C$74.85 Million-50.72%
2013 -C$0.16 Billion-4.88%
2012 -C$0.16 Billion-426.29%
2011 C$48.93 M-159.85%
2010 -C$81.77 Million35.33%
2009 -C$60.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
C$44.16 B-107,283.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.89 B-31,392.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.30 B-5,689.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.31 B-17,858.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.61 B-33,148.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-C$3.21 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA